Tag: immuno-oncology
Speakers shine light on current evidence for the ‘IOs’ and the...
Two of the sessions from day one of the 2023 European Conference on Interventional Oncology (ECIO; 16–19 April, Stockholm, Sweden) drew delegates’ focus to...
IO beyond interventional oncology: Progress in immuno-oncology
Recent advances in immuno-oncology are transforming the practice of medical oncology. Currently, antibodies directed against negative regulators of T-cell function, the so-called checkpoint inhibitors,...
Combination of immuno-oncology and liver-directed therapy: Where do we stand?
Ushering in “the era of IO”, Brad Wood calls for interventional oncologists to learn the language of immuno-oncology—“the other IO”—in order to improve care...
Interventional Oncology 2.0: Soul-searching to define our identity
Julius Chapiro and Lynn Savic claim there is “no need for scepticism” about the recent emergence and growth of immuno-oncology from an interventional oncologists’...
Surefire Medical appoints Mary T Szela CEO and president
Szela brings nearly 30 years of progressive leadership experience to Surefire building global billion-dollar brands, advancing pipeline products in the biotechnology, medical products, and...
BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme
BTG and the Society of Interventional Oncology (SIO) have expanded their commitment to the Immuno-oncology /interventional oncology research grant programme, by announcing a second...
SIO announces first grants in interventional oncology /immuno-oncology research programme
The Society of Interventional Oncology (SIO and BTG have announced their 2017 Interventional interventional oncology /immuno-oncology research grant recipients.
The interventional oncology /immuno-oncology research programme...
Interventional oncology should identify “unmet immunotherapy needs”
Daniel Sze, speaking at the ninth annual Symposium on Clinical Interventional Oncology (CIO; 4–5 February 2017, Hollywood, USA), noted that immunotherapy is a “huge...
BTG and SIO to explore role of minimally invasive therapies in...
BTG has announced a collaboration with the Society of Interventional Oncology (SIO; a global organisation working to nurture and support interventional oncology worldwide) to...
